ROYALTY PHARMA PLC's ticker is RPRX and the CUSIP is G7709Q104. A total of 312 filers reported holding ROYALTY PHARMA PLC in Q3 2023. The put-call ratio across all filers is 0.16 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $946 | -18.7% | 34,886 | -7.8% | 0.03% | -6.9% |
| Q2 2023 | $1,163 | -30.5% | 37,835 | -18.6% | 0.03% | -17.1% |
| Q1 2023 | $1,674 | -27.2% | 46,470 | -20.2% | 0.04% | -12.5% |
| Q4 2022 | $2,301 | -99.9% | 58,230 | +1.1% | 0.04% | -9.1% |
| Q3 2022 | $2,313,000 | -4.5% | 57,580 | 0.0% | 0.04% | +2.3% |
| Q2 2022 | $2,423,000 | +8.0% | 57,580 | 0.0% | 0.04% | +26.5% |
| Q1 2022 | $2,243,000 | -1.7% | 57,580 | +0.5% | 0.03% | +6.2% |
| Q4 2021 | $2,282,000 | +68.9% | 57,280 | +53.2% | 0.03% | +88.2% |
| Q3 2021 | $1,351,000 | -11.8% | 37,387 | 0.0% | 0.02% | -10.5% |
| Q2 2021 | $1,532,000 | -6.0% | 37,387 | 0.0% | 0.02% | -13.6% |
| Q1 2021 | $1,630,000 | +315.8% | 37,387 | +376.8% | 0.02% | +340.0% |
| Q4 2020 | $392,000 | – | 7,842 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| SIGULER GUFF ADVISERS, LLC | 6,761,970 | $294,957,000 | 88.74% |
| Vantage Consulting Group Inc | 8,705,551 | $379,735,000 | 76.23% |
| Memorial Sloan Kettering Cancer Center | 2,680,644 | $116,930,000 | 72.07% |
| HARVARD MANAGEMENT CO INC | 10,714,284 | $467,357,000 | 26.11% |
| ROBERT WOOD JOHNSON FOUNDATION | 970,151 | $4,231,798,000 | 21.59% |
| Brown University | 381,759 | $16,652,000 | 11.44% |
| Overbrook Management Corp | 771,155 | $33,638,000 | 7.48% |
| SpiderRock Advisors, LLC | 778,800 | $34,236,000 | 4.79% |
| Renaissance Capital LLC | 452,948 | $19,758,000 | 2.93% |
| Lagoda Investment Management, L.P. | 104,835 | $4,573,000 | 2.28% |